Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview:
The field of recombinant DNA technologies adapts nucleic acid amplification technology. INNAT is a simple method that efficiently and rapidly accumulates nucleic acid sequences at a constant temperature. Moreover, these techniques are developed as an alternative to a polymerase chain reaction. They are used for detecting and analyzing a small number of nucleic acids and biosensing targets such as DNA, RNA, cells, proteins, small molecules, and ions. It has been widely used in research, medicine, agriculture, and forensic. INAAT is preferred over PCR due to the low cost of equipment and fewer chances of contamination.
Isothermal Nucleic Acid Amplification Technology Market Insights
The isothermal nucleic acid amplification technology market size was valued at USD 1,729.0 million in 2019 and projected to grow at a CAGR of 13.8% during the forecast period, 2020-2027. The growing demand for INAAT is the primary factor due to the rising demand for molecular diagnostics and molecular testing techniques. Additionally, the increasing prevalence of infectious diseases such as HIV, Influenza, TB & other others, with rising demand for rapid diagnosis, will spur the global isothermal nucleic acid amplification technology in the future periods. Furthermore, the growing public-private funding for molecular diagnostics and the easy development of personalized medical products is expected to witness remarkable growth of isothermal technology. The increasing blood donations and rising numbers of blood transfusions are expected to propel the demand for INAAT over the coming years. Furthermore, the rise in the extensive R&D activities at the academic and industrial level and increasing scope of molecular testing are fueling the demand for INAAT in the healthcare market. Additionally, the growing geriatric population and growing healthcare demands in the developing world propelling the growth of the INAAT market across the globe.
Growth Driver
INAAT is used in molecular diagnostics, which can provide quick and effective results. It has so many applications in the healthcare industry, from research to clinics, and is rapidly adapted over PCR due to removing contamination for adequate amplification and doesn’t require a thermocycler. Moreover, Due to the advantage of low cost &precise results, it has attracted various enterprises to the layout. Hence, owing to cost-benefit and novel technology, INAAT is expected to gain profit in the future. INAAT is manufactured for the rapid testing of various diseases causing agents, introducing newer pathogens, and the rising need for molecular diagnostics. However, the extensive usage of PCR over INAAT can be a restraint to the market of the INNAT industry.
COVID-19 Impacts Insights
Recently, the outbreak of COVID-19 has vigorously affected the healthcare system of developed and developing countries globally. The growing nervousness regarding the shortage of essential medical life-saving devices and other necessary medical supplies to shut out the spread of this virus and provide optimum care to the infected also widens. Additionally, the manufacturing process’s surge for broad assays kits, reagents, and others, will enhance the demand for INAAT in the healthcare industry.
Products Segmental Analysis
The INNAT market is segregated into assays, kits & reagents, and Instruments or systems based on the product. The assay, kits, and reagents segment estimated to witness the highest growth over the analysis timeframe due to the increasing usage of diagnostics tests for infectious diseases in hospitals and diagnostics centers and the rising need for reagents in assay development and therapeutics.
The Instruments will grow significantly due to the rising adoption & utilization of isothermal technology and rapid expansion in the customer base.
Technology Type Segmental Analysis
The INAAT market is categorized into LAMP, SDA, NASBA, HAD, TMA, and other technologies based on the type of technology. The Transcription mediated amplification (TMA) segment held for a significant market share in 2019 and will gain maximum market revenue by 2027. It is attributable to the widespread use in molecular biology, forensics, and medicines for the rapid identification & diagnosis of pathogenic organisms and more reliability.
The HAD segment is poised to witness significant growth over the forecast period. It provides a rapid amplification method at an isothermic temperature and does not require a thermocycler.
Application Segmental Analysis
Based on the application, the global INAAT market is classified into Infectious diseases diagnosis, blood screening, cancer, and other applications. The Infectious diseases diagnosis is expected to be the highest revenue share for INAAT during the forecast period. The segment’s hike is primarily attributed to the rising incidence of infectious diseases and increasing demand for rapid testing to prevent them from spreading.
The Blood screening will witness a lucrative growth rate in the estimated period due to the increasing number of blood transfusions and rising diseases such as anemia, cancer, hemophilia, and kidney diseases.
End-User Segmental Analysis
The global INAAT market is segmented into hospitals, reference laboratories, and academic & research institutes based on the end-user. The hospital & surgical centers segment will dominate the global INAAT market by 2027. Due to the rise in the number of hospitals & surgical centers using isothermal technology for diagnostic testing, economic expansion, and government focus on broader healthcare policies.
The reference laboratories accounted for the largest share of the INAAT market in 2019 because of the high adoption of accurate molecular diagnostics techniques for rapidly analyzing infectious diseases.
Region Segmental Analysis
The global INAAT market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America is estimated to project considerable growth over 2020-2026. It is owing to advents in technology, the presence of leading industry players offering innovative products, and increasing healthcare expenditure.
The Asia Pacific will generate a prominent share of the INAAT market by 2027. Due to the unmet clinical needs, we are continually expanding healthcare infrastructure in the region and mounting health care expenditures in growing countries such as India and China.
Competitor Analysis
Companies such as Abbott Laboratories, Becton, BioMérieux SA, Dickinson & Company, DiaSorin S.p.A., Eikenchemical CO LTD, Hologic Inc, Grifols, Meridian Bioscience, Quidel Corporation, QIAGEN, Tecan Trading AG, Thermo Fisher Scientific Inc, GE Healthcare, and New England Biolabs are the key players in the global INAAT market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global Isothermal nucleic acid amplification technology manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to INAAT
- Regulatory bodies
- Suppliers
- Retailers
The objective of the research
- Market modeling begins with identifying a target market where historical data exists. A Market may include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps assess potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can significantly affect the target market.
- Market Segmental Analysis defines an in-depth scenario of the target market by grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics.
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs, wants, and cultural characteristics that can specifically target.
Market Modelling
By Product
- Assay, Kits & Reagents
- Instruments or systems
By Technology Type
- TMA
- LAMP
- SDA
- HAD
- NASBA
- Other technologies
By Application
- Infectious diseases diagnosis
- Blood screening
- Cancer
- Other applications
By End-User
- Hospitals
- Reference laboratories
- Academic & Research Institutes
- Other end-users
By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Anechoic Chamber Market
Global Risk Analytics Market
Tangential Flow Filtration Market
Personalized Learning Market
Bank Kiosk Market
Global Cell-Based Assays Market
Hardware in the Loop Market
Transfer Membrane Market
Human Machine Interface Market
Tangential Flow Filtration Market